Search results
15 wrz 2022 · Incidence, diagnostic methods, and evolution of left ventricular thrombus in patients with anterior myocardial infarction and low left ventricular ejection fraction: a prospective multicenter study. Am Heart J . 2015;170:256–262. doi: 10.1016/j.ahj.2015.04.029
- View EPUB
E Sg¦ƒ“ ‡9»ç§{8ƒ,»ëô r:œ æ Ü–dIyZ™ »OmŒNóŽÀ[tÝPxèŠn þ...
- Linda S. Williams
Many diseases with specific indications for specific...
- PDF/Epub
E Sg¦ƒ“ ‡9»ç§{8ƒ,»ëô r:œ æ Ü–dIyZ™ »OmŒNóŽÀ[tÝPxèŠn þ...
- Trial
Background—The Randomized Evaluation of Long-term...
- Results From the GEIST
Left ventricular (LV) thrombus formation is a well‐known...
- Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome
Objective: Takotsubo syndrome (TTS) is characterized by...
- Stroke
National Center. 7272 Greenville Ave.Dallas, TX 75231....
- Peripartum Cardiomyopathy
Peripartum cardiomyopathy is a potentially life-threatening...
- View EPUB
Setting the Time Zone for Atomic Clock Function The Model 7500E can be set to one of the four United States time zones. Additionally, two more options including no reception of WWVB signal are available with this model.
Left ventricular (LV) thrombus is a feared complication of LV dysfunction associated with high rates of systemic embolism, morbidity, and mortality. Traditionally, LV thrombus has been associated with acute myocardial infarction (MI).
Left ventricular thrombus (LVT) is a serious complication of acute myocardial infarction (MI) and also non-ischemic cardiomyopathies. We performed a narrative literature review, manual-search of reference lists of included articles and relevant reviews.
Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study. Your access to the latest cardiovascular news, science, tools and resources.
23 wrz 2022 · On the basis of limited data, patients with nonischemic cardiomyopathy with LV thrombus should be treated with OAC for at least 3–6 months, with discontinuation if LV ejection fraction improves to >35% (assuming resolution of the LV thrombus) or if major bleeding occurs.
22 paź 2024 · We aimed to describe the evolution of LV thrombus on serial cardiovascular magnetic resonance imaging (CMR) – the current reference standard for the detection of LV thrombus, and identify correlates of no resolution and the embolic risk associated with resolution status.
